AQR Capital Management - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 152 filers reported holding REATA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 3.61 and the average weighting 0.2%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$607,376
+9.5%
5,957
-3.7%
0.00%0.0%
Q1 2023$554,473
+95.2%
6,189
-28.7%
0.00%0.0%
Q1 2022$284,000
-27.7%
8,677
+170.8%
0.00%0.0%
Q4 2020$393,000
+4.0%
3,204
-18.2%
0.00%0.0%
Q3 2020$378,000
-84.3%
3,917
-74.6%
0.00%
-75.0%
Q2 2020$2,401,000
+6.0%
15,392
-1.9%
0.00%0.0%
Q1 2020$2,266,000
+10.0%
15,697
+55.8%
0.00%
+100.0%
Q4 2019$2,060,000
+133.0%
10,077
-8.5%
0.00%
+100.0%
Q3 2019$884,000
-17.5%
11,008
-3.0%
0.00%0.0%
Q2 2019$1,071,000
-32.8%
11,347
-39.1%
0.00%
-50.0%
Q1 2019$1,593,000
+49.7%
18,635
-1.8%
0.00%
+100.0%
Q4 2018$1,064,000
+179.3%
18,973
+307.0%
0.00%
Q3 2018$381,000
+44.9%
4,662
-38.1%
0.00%
Q2 2018$263,000
+15.9%
7,529
-31.9%
0.00%
Q1 2018$227,000
-27.5%
11,0500.0%0.00%
Q4 2017$313,000
-25.1%
11,050
-17.8%
0.00%
Q3 2017$418,00013,4370.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
DekaBank Deutsche Girozentrale 17,000$2,9300.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 93,711$1,6120.00%
IFP Advisors, Inc 300$51,7080.00%
View complete list of REATA PHARMACEUTICALS INC shareholders